ZA955631B - Benzopyran compounds process for their preparation and the pharmaceutical compositions which contain them - Google Patents

Benzopyran compounds process for their preparation and the pharmaceutical compositions which contain them

Info

Publication number
ZA955631B
ZA955631B ZA955631A ZA955631A ZA955631B ZA 955631 B ZA955631 B ZA 955631B ZA 955631 A ZA955631 A ZA 955631A ZA 955631 A ZA955631 A ZA 955631A ZA 955631 B ZA955631 B ZA 955631B
Authority
ZA
South Africa
Prior art keywords
alkyl
halo
alkoxy
hydroxy
contain
Prior art date
Application number
ZA955631A
Other languages
English (en)
Inventor
Gilbert Lavielle
Thierry Dubuffet
Mark Millan
Adrian Newman-Tancredi
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA955631B publication Critical patent/ZA955631B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA955631A 1994-07-06 1995-07-06 Benzopyran compounds process for their preparation and the pharmaceutical compositions which contain them ZA955631B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9408328A FR2722194B1 (fr) 1994-07-06 1994-07-06 Nouveaux derives de benzopyrane, leur procede de preparation et les compositions pharmacuetiques qui les contiennent

Publications (1)

Publication Number Publication Date
ZA955631B true ZA955631B (en) 1996-02-16

Family

ID=9465049

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA955631A ZA955631B (en) 1994-07-06 1995-07-06 Benzopyran compounds process for their preparation and the pharmaceutical compositions which contain them

Country Status (16)

Country Link
US (2) US5663191A (es)
EP (1) EP0691342B1 (es)
JP (1) JP2999139B2 (es)
CN (1) CN1049660C (es)
AT (1) ATE179421T1 (es)
AU (1) AU684165B2 (es)
CA (1) CA2153195C (es)
DE (1) DE69509308T2 (es)
DK (1) DK0691342T3 (es)
ES (1) ES2133686T3 (es)
FI (1) FI111945B (es)
FR (1) FR2722194B1 (es)
GR (1) GR3030168T3 (es)
NO (1) NO311085B1 (es)
NZ (1) NZ272501A (es)
ZA (1) ZA955631B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891882A (en) * 1996-12-06 1999-04-06 Abbott Laboratories Benzopyranopyrrole and benzopyranopyridine α-1 adenergic compounds
FR2764890B1 (fr) * 1997-06-24 1999-08-27 Adir Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5919802A (en) * 1997-12-05 1999-07-06 Princeton University Methods of preventing and/or treating temporal lobe epilepsy
TWI274750B (en) 1999-01-12 2007-03-01 Abbott Gmbh & Co Kg Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same
FR2823752B1 (fr) * 2001-04-18 2004-10-22 Servier Lab Nouveaux derives de pyrimidin-4-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB0118892D0 (en) * 2001-08-02 2001-09-26 Vernalis Res Ltd Method of treatment
US20040053968A1 (en) * 2001-12-28 2004-03-18 Hartman George D. Methods and compositions for treating peridontal disease
AU2006214233A1 (en) * 2005-02-17 2006-08-24 Wyeth Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
ES2335710T3 (es) * 2006-04-03 2010-03-31 F. Hoffmann-La Roche Ag Proceso para preparar acidos beta-aril o heteroaril carboxi-licos ciclicos enantiomericamente enriquecidos.
TW200924752A (en) 2007-09-17 2009-06-16 Organon Nv Tricyclic heterocyclic derivatives
WO2010069793A1 (en) * 2008-12-16 2010-06-24 F. Hoffmann-La Roche Ag Process for the preparation of pyrollidine-3-carboxylic acids
FR2948372B1 (fr) * 2009-07-21 2011-07-22 Servier Lab Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN105111220A (zh) * 2015-09-12 2015-12-02 浙江大学 取代1,4-二氢苯并吡喃[2,3-b]吡咯化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3518272A (en) * 1968-02-05 1970-06-30 Warner Lambert Pharmaceutical Tetrahydro benzopyranoquinolines and process for their production
US3888946A (en) * 1971-03-17 1975-06-10 Little Inc A Pyrano benzopyrans
AU560459B2 (en) * 1982-06-01 1987-04-09 Abbott Laboratories Tetrahydro-benzo(e) isoindolines
US4666916A (en) * 1985-11-08 1987-05-19 Ciba-Geigy Corporation Hexahydro-(1)-benzo-(pyrano and thiopyrano) (4,3-C)pyridines, useful as serotin-2 blocking agents
JPH03502701A (ja) * 1988-12-15 1991-06-20 アボツト・ラボラトリーズ ５‐ｈｔ選択性物質
GB8917333D0 (en) * 1989-07-28 1989-09-13 Merck Sharp & Dohme Therapeutic agents
FR2687146B1 (fr) * 1992-02-12 1994-04-01 Adir Cie Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
CN1119189A (zh) 1996-03-27
ES2133686T3 (es) 1999-09-16
AU684165B2 (en) 1997-12-04
JPH0841066A (ja) 1996-02-13
DE69509308T2 (de) 1999-11-25
DK0691342T3 (da) 1999-11-08
US5663191A (en) 1997-09-02
NO952660D0 (no) 1995-07-05
ATE179421T1 (de) 1999-05-15
EP0691342A1 (fr) 1996-01-10
EP0691342B1 (fr) 1999-04-28
FI953308A (fi) 1996-01-07
CN1049660C (zh) 2000-02-23
FI953308A0 (fi) 1995-07-05
CA2153195C (fr) 2004-06-15
US5723484A (en) 1998-03-03
FI111945B (fi) 2003-10-15
GR3030168T3 (en) 1999-08-31
NO952660L (no) 1996-01-08
FR2722194B1 (fr) 1996-08-23
NZ272501A (en) 1996-03-26
FR2722194A1 (fr) 1996-01-12
NO311085B1 (no) 2001-10-08
DE69509308D1 (de) 1999-06-02
CA2153195A1 (fr) 1996-01-07
AU2482695A (en) 1996-01-18
JP2999139B2 (ja) 2000-01-17

Similar Documents

Publication Publication Date Title
ZA955631B (en) Benzopyran compounds process for their preparation and the pharmaceutical compositions which contain them
MY123354A (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
BG103518A (en) 2-(purin-9-yl)tetrahydrofuran-3,4-diol derivatives
UA70298A (uk) Похідні с-4"-заміщених макролідів, спосіб їх одержання, проміжні сполуки, фармацевтична композиція та спосіб лікування бактеріальної інфекції або протозойної інфекції
BG103947A (en) Derivatives of 9-oxymerythromycin
MY122353A (en) 13-membered azalides and their use as antibiotic agents
BG105543A (en) Novel macrolide antibiotics
RU93053905A (ru) Оксипуриновые нуклеозиды и родственные им соединения, а также их ацильные производные для улучшения гемопоэза, фармацевтическая композиция и способ лечения и/или профилактики
TW347389B (en) Taxoids, their preparation and pharmaceutical compositions containing them
IL61911A (en) 2,3-dihydro-imidazo(1,2-b)pyridazine derivatives,their preparation and pharmaceutical compositions containing them
HUT76480A (en) Alkyl-5-methyl-sulphonyl-benzoyl-guanidine derivatives, process for the preparation thereof and pharmaceutical compositions containing them
NO972943L (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende dem og deres anvendelse
ZA934110B (en) Diacylglycerol nicotinates, process fot their preparation and the pharmaceutical compositions which contain them
IL89126A0 (en) Beta-lactam antibiotics,their preparation and pharmaceutical compositions containing them
BG103985A (en) Multicyclic derivatives of erythromycin
ES8201151A1 (es) Procedimiento para la preparacion de acidos 5-sulfamoilorta-nilicos